PointCross Life Sciences Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • PointCross Life Sciences's estimated annual revenue is currently $30.2M per year.(i)
  • PointCross Life Sciences's estimated revenue per employee is $155,000

Employee Data

  • PointCross Life Sciences has 195 Employees.(i)
  • PointCross Life Sciences grew their employee count by 7% last year.

PointCross Life Sciences's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Strategic ProgramsReveal Email/Phone
3
Technical Director, Nonclinical ProgramsReveal Email/Phone
4
Director - Human Resource & Delivery OperationsReveal Email/Phone
5
Sr. Manager ITReveal Email/Phone
6
Data Standardization Services/ SENDReveal Email/Phone
7
Member Technical StaffReveal Email/Phone
8
Software DeveloperReveal Email/Phone
9
Software EngineerReveal Email/Phone
10
Senior Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is PointCross Life Sciences?

PointCross Inc., founded in 2007 out of Foster City, CA, is a software company built to provide the life science industry solutions in big data analytics, management, and visualization. Our offerings reduce risks, improve data quality, shorten time to market, and generate better insights from R&D and regulatory data. Our technology helps global BioPharma clients as well as the FDA to support drug safety development and translational medical analytics through a suite of informatics offerings. Fo more information, please visit pointcrosslifesciences.com.

keywords:N/A

N/A

Total Funding

195

Number of Employees

$30.2M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$29.8M198-9%$36M
#2
$33.7M211N/AN/A
#3
$63.9M2156%N/A
#4
$35.2M23415%$60M
#5
$53.7M2447%N/A